myoglobinuria

Summary
Definition
A myopathy that is characterized by an increased urinary excretion of myoglobin.
Super Class
myopathy
External Links
Disease Ontology
DOID:0080108
Mondo Disease Ontology
MeSH
OMIM
Related Genes
Displaying entries 1 - 10 of 11 in total
Gene ID Gene Symbol Description Source
1376 CPT2 carnitine palmitoyltransferase 2
3030 HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
3032 HADHB hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
3033 HADH hydroxyacyl-CoA dehydrogenase
3939 LDHA lactate dehydrogenase A
5224 PGAM2 phosphoglycerate mutase 2
5230 PGK1 phosphoglycerate kinase 1
5837 PYGM glycogen phosphorylase, muscle associated
9663 LPIN2 lipin 2
23175 LPIN1 lipin 1
Displaying 1 entry
Gene ID Gene Symbol Description Source
56012 Pgam2 phosphoglycerate mutase 2
Displaying 1 entry
Gene ID Gene Symbol Description Source
24959 Pgam2 phosphoglycerate mutase 2
Displaying 1 entry
Gene ID Gene Symbol Description Source
853705 GPM1 phosphoglycerate mutase GPM1
The Human Phenotype Ontology
Displaying entries 11 - 20 of 36 in total
HPO ID HPO Term
HP:0100520 Oliguria
HP:0002901 Hypocalcemia
HP:0005216 Impaired mastication
HP:0000083 Renal insufficiency
HP:0003394 Muscle spasm
HP:0008305 Exercise-induced myoglobinuria
HP:0001919 Acute kidney injury
HP:0012544 Elevated circulating aldolase concentration
HP:0002355 Difficulty walking
HP:0003738 Exercise-induced myalgia
Displaying 1 entry
Gene ID Gene Symbol Description
23175 LPIN1 lipin 1

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024